Acquisition by Butitta Cynthia M of 44000 shares of Century Therapeutics subject to Rule 16b-3

IPSC Stock  USD 1.55  0.13  7.74%   
About 66% of Century Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Century Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Century Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Century Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Century Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Century insider trading alert for grant of stock option right to buy by Butitta Cynthia M, the corporate stakeholder, on 29th of June 2023. This event was filed by Century Therapeutics Inc with SEC on 2023-06-29. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Century Therapeutics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Century Therapeutics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Century Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Century Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Century Therapeutics Fundamental Analysis

We analyze Century Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Century Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Century Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Earning

Price To Earning Comparative Analysis

Century Therapeutics is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Century Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Century Therapeutics stock to make a market-neutral strategy. Peer analysis of Century Therapeutics could also be used in its relative valuation, which is a method of valuing Century Therapeutics by comparing valuation metrics with similar companies.

Peers

Century Therapeutics Related Equities

KROSKeros Therapeutics   9.78   
0%
82.0%
EWTXEdgewise Therapeutics   1.33   
0%
11.0%
BPMCBlueprint Medicines   1.12   
9.0%
0%
CGEMCullinan Oncology   2.81   
23.0%
0%
GLUEMonte Rosa   3.52   
29.0%
0%
GBIOGeneration Bio   3.52   
29.0%
0%
KZRKezar Life   4.59   
38.0%
0%
MLYSMineralys Therapeutics,   4.60   
38.0%
0%
ERASErasca   4.95   
41.0%
0%
STOKStoke Therapeutics   5.30   
44.0%
0%
CCCCC4 Therapeutics   5.58   
46.0%
0%
RLAYRelay Therapeutics   6.00   
50.0%
0%
NKTXNkarta   10.89   
91.0%
0%
PASGPassage Bio   11.88   
100.0%
0%

Complementary Tools for Century Stock analysis

When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges